摘要
研究前列腺癌的导向酶前体药物疗法(ADEPT),在体外观察前体药物甲氨喋呤α肽对前列腺癌细胞生长、凋亡的影响。用固相合成法合成了前体药物甲氨喋呤α苯丙氨酸(MTXαPhe)和甲氨喋呤α精氨酸(MTXαArg),并对前列腺癌细胞PC3、PC3m进行了细胞毒性及周期动力学分析。用高效液相色谱及质谱分析,MTXαPhe可被羧肽酶A(CPA)水解并且完全释放出MTX。经体外对前列腺癌细胞的毒性试验,前体药物基本上对细胞无毒,经CPA水解后其活性MTX细胞毒性大于前体药物100倍以上。对前列腺癌细胞具有显著抑制作用,S期比率明显低于对照组,G0/G1期比率高于对照组,细胞增殖指数明显减低,细胞并发生凋亡。认为MTXαPhe是一较理想的前体药物。
In order to study the efficiency of the antibody directed enzyme prodrug therapy (ADEPT),the effect of MTX α peptides on growth and apoptosis of the prostatic cancer cells was studied.Methotrexate a Phenylalanine (MTX α Phe) and Methotrexate a arginine (MTX α Arg) were used as prodrugs synthesised by solid phase methods.The cytotoxin and cell cycle of prostatic cancer cells,PC 3 and PC 3m were determined.MTX α Phe was hydrolyzed into MTX by carboxypeptidase (CPA) using HPLC and Mass Spectrograph.The cytotoxin effect of the products enzymed by CPA was 100 times higher than that of the prodrugs with no obvious cytotoxin on the cells in vitro and former showed an obvious inhibition effects on the cells.Their cell cycle was determined and S phase fraction was lower than the control group,G 0/G 1 fraction was higher and the perliferation index obviously decreased resulting in apoptosis of the cancer cells.MTX α Phe would be considered an excellent prodrug.
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
1997年第10期583-584,共2页
Chinese Journal of Urology
基金
国家自然科学基金青年基金
陕西省自然科学研究计划项目基金